Follow on Google News News By Tag * Healthcare * Uae * Dubai * Pharmaceutical * Hospital * Conditions * Merck * Serono * Dhabi * Abu * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | Just Released: "United Arab Emirates Pharmaceuticals & Healthcare Report Q3 2011"Fast Market Research recommends "United Arab Emirates Pharmaceuticals & Healthcare Report Q3 2011" from Business Monitor International, now available
------------------------------------------------------------ Full Report Details at - http://www.fastmr.com/ ------------------------------------------------------------ Headline Expenditure Projections * Pharmaceuticals: * Healthcare: * Medical devices: AED2.93bn (US$797mn) in 2010 to AED3.25bn (US$886mn) in 2011; +11.1% in local currency terms and +11.1% in US dollar terms. Forecast up marginally from Q211 due to analyst modification. Business Environment Rating: The pharmaceutical rating for the UAE in Q311 remains unchanged at 63.6 out of 100, which is well above the average of 47.4 for the region. The country continues to occupy pole position in BMI's Q311Business Environment Ratings for the Middle East and Africa region, with an unchanged Industry Rewards score of 57. Factors such as the population's wealth and the rise in the incidence of lifestyle-related diseases in the Middle East are making pharmaceutical markets such as the UAE an attractive investment proposition. Key Trends & Developments * Provisional data issued by the World Intellectual Property Organisation (WIPO) has revealed that, international patent filings by Gulf countries under WIPO's Patent Cooperation Treaty rose 14.56% to 118 in 2010, compared to 103 in 2009 and despite troubled economic conditions. Saudi Arabia had the most patent filings with 78, followed by the UAE with 29, Qatar with seven, and Oman with four; while Kuwait and Bahrain failed to register any patent filings last year. * In March 2011, the Ministry of Health announced that the price of drugs used for treating chronic diseases will be reduced by up to 15%. The costs of 177 types of medicines in the UAE are currently much higher than in other countries in the region. In the UAE, a large section of the population suffers from chronic ailments such as Type 2 diabetes and cardiovascular diseases. * Figures published by the 'Beat Obesity Campaign' have revealed that over 32% of schoolchildren in Dubai are overweight or obese. Meanwhile, a study conducted by the UAE Ministry of Health, the Centre for Disease Control in the US, and the World Health Organization has revealed that as per 2010 statistics, 54.7% of children living in the UAE between the ages of six and 16 were classed in the overweight and obese category. In 2009, however, the figure was 26%. * Elsewhere, the Abu Dhabi Health Services Company announced that it had begun construction work on the new Mafraq Hospital, estimated at a cost AED2.2bn (US$598mn). The new Mafraq premises will be located adjacent to the existing Mafraq facility in Abu Dhabi. The new hospital, which will contain 739 beds and provide 139 outpatient clinics, will also serve as a centre of excellence in thoracic and orthopaedic surgery, and burns treatment within the Emirate. * In other developments, a new authority was unveiled to oversee the functions of the Dubai Healthcare City, as well as to provide a boost to the Emirate as a hub for medical tourism. The Dubai Healthcare City Authority has been established as part of plans to attract a whole spectrum of complementary industries, ranging from drug manufacturers, to research laboratories and pharmacies. The new authority also hopes to attract leading specialists and healthcare professionals to the Emirate. BMI Economic View: Favourable macroeconomic factors such as increasing fiscal expenditure and real GDP growth values are expected to facilitate the expansion of the UAE's pharmaceutical market. In 2010, fiscal expenditure reached a value of AED298.64bn; Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets. BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports. Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports. View more research from Business Monitor International at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number